In another setback for the pharma industry, a US federal judge has rejected a bid to overturn the Medicare pricing negotiation brought by Bristol-Myers Squibb and Johnson & Johnson.
Judge Zahid Quraishi came down on the side of the US government in the case, heard in New Jersey, which challenges the legality of the negotiation powers introduced by the Biden administration as part of the wide-ranging Inflation Reduction Act (IRA).
